4.6 Article

Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Angiogenesis Inhibitors in Small Cell Lung Cancer

Agnese Montanino et al.

Summary: Inhibition of angiogenesis has shown efficacy in treating SCLC, with anlotinib being the only drug that has demonstrated improvement in both overall survival (OS) and progression-free survival (PFS) in Chinese patients. Future challenges include evaluating angiogenesis inhibitors in combination with immune-checkpoint inhibitors and chemotherapy in SCLC patients, as well as identifying predictive biomarkers of response to these agents.

FRONTIERS IN ONCOLOGY (2021)

Article Multidisciplinary Sciences

Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells

Prashanth K. B. Nagesh et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression

Sugandha Bhatia et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Article Chemistry, Physical

Tannic acid-inspired paclitaxel nanoparticles for enhanced anticancer effects in breast cancer cells

Pallabita Chowdhury et al.

JOURNAL OF COLLOID AND INTERFACE SCIENCE (2019)

Article Materials Science, Biomaterials

Development of Zoledronic Acid-Based Nanoassemblies for Bone-Targeted Anticancer Therapy

Elham Hatami et al.

ACS BIOMATERIALS SCIENCE & ENGINEERING (2019)

Article Biochemistry & Molecular Biology

Cytoproliferative and Anti-Oxidant Effects Induced by Tannic Acid in Human Embryonic Kidney (Hek-293) Cells

Pearl O. Perumal et al.

BIOMOLECULES (2019)

Article Biochemistry & Molecular Biology

Mannose-decorated hybrid nanoparticles for enhanced macrophage targeting

Elham Hatami et al.

BIOCHEMISTRY AND BIOPHYSICS REPORTS (2019)

Article Nanoscience & Nanotechnology

Tannic acid-modified silver nanoparticles for wound healing: the importance of size

Piotr Orlowski et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)

Review Oncology

Unraveling the Role of Angiogenesis in Cancer Ecosystems

Iratxe Zuazo-Gaztelu et al.

FRONTIERS IN ONCOLOGY (2018)

Article Cell Biology

Tannic acid inhibits EGFR/STAT1/3 and enhances p38/STAT1 signalling axis in breast cancer cells

Pramod Darvin et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2017)

Review Oncology

Broad targeting of angiogenesis for cancer prevention and therapy

Zongwei Wang et al.

SEMINARS IN CANCER BIOLOGY (2015)

Article Oncology

The Role of Anti-angiogenesis in Non-small-cell Lung Cancer: an Update

Liza C. Villaruz et al.

CURRENT ONCOLOGY REPORTS (2015)

Review Biotechnology & Applied Microbiology

Oxidative Stress, Prooxidants, and Antioxidants: The Interplay

Anu Rahal et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Article Oncology

Tannic Acid Preferentially Targets Estrogen Receptor-Positive Breast Cancer

Brian W. Booth et al.

INTERNATIONAL JOURNAL OF BREAST CANCER (2013)

Review Oncology

Tumor Vasculature as a Therapeutic Target in Non-small Cell Lung Cancer

Jair Bar et al.

JOURNAL OF THORACIC ONCOLOGY (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Respiratory System

Lung Cancer: Epidemiology, Etiology, and Prevention

Charles S. Dela Cruz et al.

CLINICS IN CHEST MEDICINE (2011)

Review Multidisciplinary Sciences

Molecular mechanisms and clinical applications of angiogenesis

Peter Carmeliet et al.

NATURE (2011)

Review Cell Biology

Molecular interactions in cancer cell metastasis

Susan A. Brooks et al.

ACTA HISTOCHEMICA (2010)

Review Chemistry, Medicinal

Antimicrobial and Antiviral Activity of Hydrolysable Tannins

Pietro Buzzini et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2008)

Review Oncology

Angiogenesis and lung cancer: Prognostic and therapeutic implications

RS Herbst et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Review Biochemistry & Molecular Biology

The biology of VEGF and its receptors

N Ferrara et al.

NATURE MEDICINE (2003)